| Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer (NCT07149363) | Alliance Foundation Trials, LLC. | 2026-02-12 |
| Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer (NCT06963723) | Alliance Foundation Trials, LLC. | 2025-07-01 |
| Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC (NCT05798663) | Alliance Foundation Trials, LLC. | 2023-12-07 |
| Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM (NCT05408026) | Alliance Foundation Trials, LLC. | 2022-10-01 |
| A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (NCT04486352) | Alliance Foundation Trials, LLC. | 2021-10-20 |
| Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide (NCT04335682) | Alliance Foundation Trials, LLC. | 2021-08-17 |
| CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer (NCT04062708) | Alliance Foundation Trials, LLC. | 2021-03-10 |
| Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM (NCT04009109) | Alliance Foundation Trials, LLC. | 2020-10-21 |
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease (NCT03656627) | Alliance Foundation Trials, LLC. | 2019-06-27 |
| Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma (NCT03478514) | Alliance Foundation Trials, LLC. | 2018-09-11 |
| Atezolizumab Immunotherapy in Patients With Advanced NSCLC (NCT03102242) | Alliance Foundation Trials, LLC. | 2017-11-01 |
| Electronic Patient Reporting of Symptoms During Cancer Treatment (NCT03249090) | Alliance Foundation Trials, LLC. | 2017-10-30 |